Structure and activation of the TSH receptor transmembrane domain
暂无分享,去创建一个
[1] R. Paschke,et al. Rearrangement of the Extracellular Domain/Extracellular Loop 1 Interface Is Critical for Thyrotropin Receptor Activation* , 2016, The Journal of Biological Chemistry.
[2] Keren Gu,et al. Current updates on computer aided protein modeling and designing. , 2016, International journal of biological macromolecules.
[3] Marie Chabbert,et al. Molecular Insights into the Transmembrane Domain of the Thyrotropin Receptor , 2015, PloS one.
[4] R. Aronstam,et al. Constitutive Activity among Orphan Class-A G Protein Coupled Receptors , 2015, PloS one.
[5] Mihaly Mezei,et al. Monte Carlo loop refinement and virtual screening of the thyroid-stimulating hormone receptor transmembrane domain , 2015, Journal of biomolecular structure & dynamics.
[6] A. Rajkovic,et al. Novel Inactivating Mutation of the FSH Receptor in Two Siblings of Indian Origin With Premature Ovarian Failure. , 2015, The Journal of clinical endocrinology and metabolism.
[7] M. Mezei,et al. Transmembrane domains of attraction on the TSH receptor. , 2015, Endocrinology.
[8] S. Mahale,et al. Functional characterization of two naturally occurring mutations (Val514Ala and Ala575Val) in follicle-stimulating hormone receptor. , 2015, The Journal of clinical endocrinology and metabolism.
[9] Benjamin G Tehan,et al. Unifying family A GPCR theories of activation. , 2014, Pharmacology & therapeutics.
[10] R. Paschke,et al. A newly discovered TSHR variant (L665F) associated with nonautoimmune hyperthyroidism in an Austrian family induces constitutive TSHR activation by steric repulsion between TM1 and TM7. , 2014, The Journal of clinical endocrinology and metabolism.
[11] Gert Vriend,et al. Alpha-Bulges in G Protein-Coupled Receptors , 2014, International journal of molecular sciences.
[12] S. Mahale,et al. Mutations and polymorphisms in FSH receptor: functional implications in human reproduction. , 2013, Reproduction.
[13] J. Wess,et al. Activation and allosteric modulation of a muscarinic acetylcholine receptor , 2013, Nature.
[14] K. Garcia,et al. Adrenaline-activated structure of the β2-adrenoceptor stabilized by an engineered nanobody , 2013, Nature.
[15] Bryan L. Roth,et al. Structure of the human smoothened receptor bound to an antitumour agent , 2013, Nature.
[16] Nagarajan Vaidehi,et al. Critical analysis of the successes and failures of homology models of G protein‐coupled receptors , 2013, Proteins.
[17] Soo-bin Park. Hepatitis E vaccine debuts , 2012, Nature.
[18] Cheng Zhang,et al. High-resolution Crystal Structure of Human Protease-activated Receptor 1 Bound to the Antagonist Vorapaxar Hhs Public Access , 2022 .
[19] S. Opella,et al. Structure of the Chemokine Receptor CXCR1 in Phospholipid Bilayers , 2012, Nature.
[20] Xuliang Jiang,et al. Structure of follicle-stimulating hormone in complex with the entire ectodomain of its receptor , 2012, Proceedings of the National Academy of Sciences.
[21] Aashish Manglik,et al. Structure of the δ-opioid receptor bound to naltrindole , 2012, Nature.
[22] Bryan L. Roth,et al. Structure of the Nociceptin/Orphanin FQ Receptor in Complex with a Peptide Mimetic , 2012, Nature.
[23] L. Pardo,et al. Crystal structure of the μ-opioid receptor bound to a morphinan antagonist , 2012, Nature.
[24] Albert C. Pan,et al. Structure and Dynamics of the M3 Muscarinic Acetylcholine Receptor , 2012, Nature.
[25] Hugh Rosen,et al. Crystal Structure of a Lipid G Protein–Coupled Receptor , 2012, Science.
[26] Bryan L. Roth,et al. Structure of the human kappa opioid receptor in complex with JDTic , 2012, Nature.
[27] A. Grüters,et al. New pathogenic thyrotropin receptor mutations decipher differentiated activity switching at a conserved helix 6 motif of family A GPCR. , 2012, The Journal of clinical endocrinology and metabolism.
[28] A. Kruse,et al. Structure of the human M2 muscarinic acetylcholine receptor bound to an antagonist , 2011, Nature.
[29] A. Grüters,et al. Molecular description of non-autoimmune hyperthyroidism at a neonate caused by a new thyrotropin receptor germline mutation , 2011, Thyroid research.
[30] S. Rasmussen,et al. Crystal Structure of the β2Adrenergic Receptor-Gs protein complex , 2011, Nature.
[31] Ruben Abagyan,et al. Structure of the human histamine H1 receptor complex with doxepin , 2011, Nature.
[32] Catherine L. Worth,et al. From Molecular Details of the Interplay between Transmembrane Helices of the Thyrotropin Receptor to General Aspects of Signal Transduction in Family A G-protein-coupled Receptors (GPCRs)* , 2011, The Journal of Biological Chemistry.
[33] R. Núñez Miguel,et al. Crystal structure of the TSH receptor (TSHR) bound to a blocking-type TSHR autoantibody. , 2011, Journal of molecular endocrinology.
[34] Oliver P. Ernst,et al. Crystal structure of metarhodopsin II , 2011, Nature.
[35] R. Paschke,et al. Lack of in vitro constitutive activity for four previously reported TSH receptor mutations identified in patients with nonautoimmune hyperthyroidism and hot thyroid carcinomas , 2010, Clinical endocrinology.
[36] R. Abagyan,et al. Structures of the CXCR4 Chemokine GPCR with Small-Molecule and Cyclic Peptide Antagonists , 2010, Science.
[37] Gerd Krause,et al. Signaling‐sensitive amino acids surround the allosteric ligand binding site of the thyrotropin receptor , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[38] A. Pinchera,et al. Functional studies of new TSH receptor (TSHr) mutations identified in patients affected by hypothyroidism or isolated hyperthyrotrophinaemia , 2009, Clinical endocrinology.
[39] R. Stevens,et al. The 2.6 Angstrom Crystal Structure of a Human A2A Adenosine Receptor Bound to an Antagonist , 2008, Science.
[40] Gebhard F. X. Schertler,et al. Structure of a β1-adrenergic G-protein-coupled receptor , 2008, Nature.
[41] Tsutomu Kouyama,et al. Crystal structure of squid rhodopsin , 2008, Nature.
[42] F. Fanelli,et al. Intrinsic Differences in the Response of the Human Lutropin Receptor Versus the Human Follitropin Receptor to Activating Mutations* , 2007, Journal of Biological Chemistry.
[43] T. Blundell,et al. Crystal structure of the TSH receptor in complex with a thyroid-stimulating autoantibody. , 2007, Thyroid : official journal of the American Thyroid Association.
[44] A. Miyauchi,et al. Sporadic congenital hyperthyroidism due to a germline mutation in the thyrotropin receptor gene (Leu 512 Gln) in a Japanese patient. , 2006, Endocrine journal.
[45] L. Pardo,et al. THE SEVENTH TRANSMEMBRANE DOMAINS OF THE δ AND κ OPIOID RECEPTORS HAVE DIFFERENT ACCESSIBILITY PATTERNS AND INTERHELICAL INTERACTIONS , 2005 .
[46] A. Themmen. An update of the pathophysiology of human gonadotrophin subunit and receptor gene mutations and polymorphisms. , 2005, Reproduction.
[47] Leonardo Pardo,et al. An Activation Switch in the Rhodopsin Family of G Protein-coupled Receptors , 2005, Journal of Biological Chemistry.
[48] Wayne A. Hendrickson,et al. Structure of human follicle-stimulating hormone in complex with its receptor , 2005, Nature.
[49] T. Blundell,et al. Analysis of the thyrotropin receptor-thyrotropin interaction by comparative modeling. , 2004, Thyroid : official journal of the American Thyroid Association.
[50] Y. Xing,et al. Model of Glycoprotein Hormone Receptor Ligand Binding and Signaling* , 2004, Journal of Biological Chemistry.
[51] Marcus Elstner,et al. The retinal conformation and its environment in rhodopsin in light of a new 2.2 A crystal structure. , 2004, Journal of molecular biology.
[52] R. Seifert,et al. Constitutive activity of G-protein-coupled receptors: cause of disease and common property of wild-type receptors , 2002, Naunyn-Schmiedeberg's Archives of Pharmacology.
[53] F. Fanelli,et al. A Model for Constitutive Lutropin Receptor Activation Based on Molecular Simulation and Engineered Mutations in Transmembrane Helices 6 and 7* , 2002, The Journal of Biological Chemistry.
[54] K. Aittomäki,et al. A Novel mutation in the FSH receptor inhibiting signal transduction and causing primary ovarian failure. , 2002, The Journal of clinical endocrinology and metabolism.
[55] R. Paschke,et al. A free carboxylate oxygen in the side chain of position 674 in transmembrane domain 7 is necessary for TSH receptor activation. , 2001, Molecular endocrinology.
[56] S. Wodak,et al. A Conserved Asn in Transmembrane Helix 7 Is an On/Off Switch in the Activation of the Thyrotropin Receptor* , 2001, The Journal of Biological Chemistry.
[57] I. Huhtaniemi,et al. Mutations of gonadotropins and gonadotropin receptors: elucidating the physiology and pathophysiology of pituitary-gonadal function. , 2000, Endocrine reviews.
[58] T. Mori,et al. A novel activating mutation in the thyrotropin receptor gene in an autonomously functioning thyroid nodule developed by a Japanese patient. , 2000, European journal of endocrinology.
[59] K. Palczewski,et al. Crystal Structure of Rhodopsin: A G‐Protein‐Coupled Receptor , 2002, Chembiochem : a European journal of chemical biology.
[60] A. Abell,et al. Constitutive activation of G protein-coupled receptors as a result of selective substitution of a conserved leucine residue in transmembrane helix III. , 2000, Molecular endocrinology.
[61] P. J. van der Spek,et al. The three subfamilies of leucine-rich repeat-containing G protein-coupled receptors (LGR): identification of LGR6 and LGR7 and the signaling mechanism for LGR7. , 2000, Molecular endocrinology.
[62] E. Milgrom,et al. New natural inactivating mutations of the follicle-stimulating hormone receptor: correlations between receptor function and phenotype. , 1999, Molecular endocrinology.
[63] J. Martens,et al. A limited repertoire of mutations of the luteinizing hormone (LH) receptor gene in familial and sporadic patients with male LH-independent precocious puberty. , 1999, The Journal of clinical endocrinology and metabolism.
[64] E. Milgrom,et al. A novel phenotype related to partial loss of function mutations of the follicle stimulating hormone receptor. , 1998, The Journal of clinical investigation.
[65] Xuebo Liu,et al. A unique constitutively activating mutation in third transmembrane helix of luteinizing hormone receptor causes sporadic male gonadotropin-independent precocious puberty. , 1998, The Journal of clinical endocrinology and metabolism.
[66] J. Martens,et al. A homozygous mutation in the luteinizing hormone receptor causes partial Leydig cell hypoplasia: correlation between receptor activity and phenotype. , 1998, Molecular endocrinology.
[67] E. Nieschlag,et al. A mutation in the first transmembrane domain of the lutropin receptor causes male precocious puberty. , 1998, The Journal of clinical endocrinology and metabolism.
[68] S J Gange,et al. Epidemiology and estimated population burden of selected autoimmune diseases in the United States. , 1997, Clinical immunology and immunopathology.
[69] P. Rocmans,et al. Diversity and prevalence of somatic mutations in the thyrotropin receptor and Gs alpha genes as a cause of toxic thyroid adenomas. , 1997, The Journal of clinical endocrinology and metabolism.
[70] S. Filetti,et al. Thyrotropin receptor gene alterations in thyroid hyperfunctioning adenomas. , 1996, The Journal of clinical endocrinology and metabolism.
[71] H. Brunner,et al. A missense mutation in the second transmembrane segment of the luteinizing hormone receptor causes familial male-limited precocious puberty. , 1995, The Journal of clinical endocrinology and metabolism.
[72] S. Swillens,et al. Somatic and germline mutations of the TSH receptor gene in thyroid diseases. , 1995, The Journal of clinical endocrinology and metabolism.
[73] C. Tsigos,et al. A novel mutation of the luteinizing hormone receptor gene causing male gonadotropin-independent precocious puberty. , 1995, The Journal of clinical endocrinology and metabolism.
[74] L. Blomberg,et al. Genetic heterogeneity of constitutively activating mutations of the human luteinizing hormone receptor in familial male-limited precocious puberty. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[75] E. Mariman,et al. Male pseudohermaphroditism due to a homozygous missense mutation of the luteinizing hormone receptor gene , 1995, Nature Genetics.
[76] J. Thompson,et al. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. , 1994, Nucleic acids research.
[77] A. Porcellini,et al. Novel mutations of thyrotropin receptor gene in thyroid hyperfunctioning adenomas. Rapid identification by fine needle aspiration biopsy. , 1994, The Journal of clinical endocrinology and metabolism.
[78] T. Blundell,et al. Comparative protein modelling by satisfaction of spatial restraints. , 1993, Journal of molecular biology.
[79] T. Minegishi,et al. A constitutively activating mutation of the luteinizing hormone receptor in familial male precocious puberty , 1993, Nature.
[80] S. McLachlan,et al. Autoantibodies to the thyrotropin receptor. , 1988, Endocrine reviews.
[81] Wen-Hsin Lee,et al. Adrenaline-activated structure of β2-adrenoceptor stabilized by an engineered nanobody , 2013 .
[82] Vadim Cherezov,et al. Diversity and modularity of G protein-coupled receptor structures. , 2012, Trends in pharmacological sciences.
[83] R. Stevens,et al. Structure of the human k-opioid receptor in complex with JDTic , 2012 .
[84] G. Krause,et al. Mutations that silence constitutive signaling activity in the allosteric ligand-binding site of the thyrotropin receptor , 2010, Cellular and Molecular Life Sciences.
[85] R. Stevens,et al. High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor. , 2007, Science.
[86] L. Pardo,et al. The seventh transmembrane domains of the delta and kappa opioid receptors have different accessibility patterns and interhelical interactions. , 2005, Biochemistry.
[87] A. Sali,et al. Modeller: generation and refinement of homology-based protein structure models. , 2003, Methods in enzymology.
[88] J. Martens,et al. Mutant luteinizing hormone receptors in a compound heterozygous patient with complete Leydig cell hypoplasia: abnormal processing causes signaling deficiency. , 2002, The Journal of clinical endocrinology and metabolism.
[89] Knut Krohn,et al. Detection of thyroid-stimulating hormone receptor and Gsα mutations: in 75 toxic thyroid nodules by denaturing gradient gel electrophoresis , 2001, Journal of Molecular Medicine.
[90] C. Brain,et al. A novel luteinizing hormone receptor mutation in a patient with familial male-limited precocious puberty: effect of the size of a critical amino acid on receptor activity. , 1999, Molecular genetics and metabolism.
[91] J. Ballesteros,et al. [19] Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein-coupled receptors , 1995 .